// App-Quantinova.ai

P366 : The efficacy of vedolizumab for induction of clinical response and remission in anti-TNF naïve patients with inflammatory bowel disease – a multicenter European real world experience

Researchers

Presenter

  • U. Kopylov

Principal Investigators

  • S. Sebastian

  • Y. Ron

  • P.R. Steinhagen

  • X. Roblin

  • D. Pugliese

  • A. Bar-Gil Shitrit

  • K. Katsanos

  • G. Fiorino

  • M. Allocca

  • T. Sipponen

  • B. Ungar

  • A. Armuzzi

  • R. Eliakim

  • D. Christodoulou

  • D.C. Baumgart

  • S. Ben-Horin

  • I. Dotan

Medical Centers

  • Sheba Medical Center, Department of Gastroenterology, Tel Hashomer, Israel

  • Hull Royal Infirmary, Hull & East Yorkshire Hospitals NHS Trust, Department of Gastroenterology and Hepatology, Hull, United Kingdom

  • Tel Aviv Medical Centre, IBD Centre, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel

  • Charité - University Hospital Berlin, Campus Benjamin Franklin, Department of Gastroenterology and Medicine I, Berlin, Germany

  • CHU de Saint-Etienne, Gastroenterology, Saint-Etiennne, France

  • Complesso Integrato Columbus, Fondazione Policlinico Gemelli Universita' Cattolica, Internal Medicine and Gastroenterology, Rome, Italy

  • Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel

  • University of Ioannina, Gastroenterology, Ioannina, Greece

  • Humanitas Research Hospital, Department of Gastroenterology, IBD Center, Rozzano, Italy

  • Humanitas Gradenigo, Gastroenterology, Turin, Italy

  • Helsinki University Central Hospital - Meilahti Hospital, Department of Gastroenterology, Helsinki, Finl

  • Chaim Sheba Medical Center, Gastroenterology, Ramat Gan, Israel

Locations

  • Israel

  • United Kingdom

  • Germany

  • France

  • Italy

  • Greece

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • Entyvio

Outcome

  • N/A


Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A